227 related articles for article (PubMed ID: 30097175)
21. Arl2-Mediated Allosteric Release of Farnesylated KRas4B from Shuttling Factor PDEδ.
Ozdemir ES; Jang H; Gursoy A; Keskin O; Nussinov R
J Phys Chem B; 2018 Aug; 122(30):7503-7513. PubMed ID: 29961325
[TBL] [Abstract][Full Text] [Related]
22. Small molecule binding sites on the Ras:SOS complex can be exploited for inhibition of Ras activation.
Winter JJ; Anderson M; Blades K; Brassington C; Breeze AL; Chresta C; Embrey K; Fairley G; Faulder P; Finlay MR; Kettle JG; Nowak T; Overman R; Patel SJ; Perkins P; Spadola L; Tart J; Tucker JA; Wrigley G
J Med Chem; 2015 Mar; 58(5):2265-74. PubMed ID: 25695162
[TBL] [Abstract][Full Text] [Related]
23. Mechanism of SOS PR-domain autoinhibition revealed by single-molecule assays on native protein from lysate.
Lee YK; Low-Nam ST; Chung JK; Hansen SD; Lam HYM; Alvarez S; Groves JT
Nat Commun; 2017 Apr; 8():15061. PubMed ID: 28452363
[TBL] [Abstract][Full Text] [Related]
24. One Atom Makes All the Difference: Getting a Foot in the Door between SOS1 and KRAS.
Ramharter J; Kessler D; Ettmayer P; Hofmann MH; Gerstberger T; Gmachl M; Wunberg T; Kofink C; Sanderson M; Arnhof H; Bader G; Rumpel K; Zöphel A; Schnitzer R; Böttcher J; O'Connell JC; Mendes RL; Richard D; Pototschnig N; Weiner I; Hela W; Hauer K; Haering D; Lamarre L; Wolkerstorfer B; Salamon C; Werni P; Munico-Martinez S; Meyer R; Kennedy MD; Kraut N; McConnell DB
J Med Chem; 2021 May; 64(10):6569-6580. PubMed ID: 33719426
[TBL] [Abstract][Full Text] [Related]
25. Small Molecule-Mediated Activation of RAS Elicits Biphasic Modulation of Phospho-ERK Levels that Are Regulated through Negative Feedback on SOS1.
Howes JE; Akan DT; Burns MC; Rossanese OW; Waterson AG; Fesik SW
Mol Cancer Ther; 2018 May; 17(5):1051-1060. PubMed ID: 29440291
[TBL] [Abstract][Full Text] [Related]
26. Allosteric Activation of RhoA Complexed with p115-RhoGEF Deciphered by Conformational Dynamics.
Haspel N; Jang H; Nussinov R
J Chem Inf Model; 2024 Feb; 64(3):862-873. PubMed ID: 38215280
[TBL] [Abstract][Full Text] [Related]
27. Influence of guanine nucleotides on complex formation between Ras and CDC25 proteins.
Lai CC; Boguski M; Broek D; Powers S
Mol Cell Biol; 1993 Mar; 13(3):1345-52. PubMed ID: 8441380
[TBL] [Abstract][Full Text] [Related]
28. Approach for targeting Ras with small molecules that activate SOS-mediated nucleotide exchange.
Burns MC; Sun Q; Daniels RN; Camper D; Kennedy JP; Phan J; Olejniczak ET; Lee T; Waterson AG; Rossanese OW; Fesik SW
Proc Natl Acad Sci U S A; 2014 Mar; 111(9):3401-6. PubMed ID: 24550516
[TBL] [Abstract][Full Text] [Related]
29. The higher level of complexity of K-Ras4B activation at the membrane.
Jang H; Banerjee A; Chavan TS; Lu S; Zhang J; Gaponenko V; Nussinov R
FASEB J; 2016 Apr; 30(4):1643-55. PubMed ID: 26718888
[TBL] [Abstract][Full Text] [Related]
30. Involvement of the switch 2 domain of Ras in its interaction with guanine nucleotide exchange factors.
Quilliam LA; Hisaka MM; Zhong S; Lowry A; Mosteller RD; Han J; Drugan JK; Broek D; Campbell SL; Der CJ
J Biol Chem; 1996 May; 271(19):11076-82. PubMed ID: 8626650
[TBL] [Abstract][Full Text] [Related]
31. Molecular assemblies of the catalytic domain of SOS with KRas and oncogenic mutants.
Moghadamchargari Z; Shirzadeh M; Liu C; Schrecke S; Packianathan C; Russell DH; Zhao M; Laganowsky A
Proc Natl Acad Sci U S A; 2021 Mar; 118(12):. PubMed ID: 33723061
[TBL] [Abstract][Full Text] [Related]
32. Understanding SOS (Son of Sevenless).
Pierre S; Bats AS; Coumoul X
Biochem Pharmacol; 2011 Nov; 82(9):1049-56. PubMed ID: 21787760
[TBL] [Abstract][Full Text] [Related]
33. Ras-15A protein shares highly similar dominant-negative biological properties with Ras-17N and forms a stable, guanine-nucleotide resistant complex with CDC25 exchange factor.
Chen SY; Huff SY; Lai CC; Der CJ; Powers S
Oncogene; 1994 Sep; 9(9):2691-8. PubMed ID: 8058333
[TBL] [Abstract][Full Text] [Related]
34. A mouse CDC25-like product enhances the formation of the active GTP complex of human ras p21 and Saccharomyces cerevisiae RAS2 proteins.
Jacquet E; Vanoni M; Ferrari C; Alberghina L; Martegani E; Parmeggiani A
J Biol Chem; 1992 Dec; 267(34):24181-3. PubMed ID: 1447167
[TBL] [Abstract][Full Text] [Related]
35. Insight into the mechanism of allosteric activation of PI3Kα by oncoprotein K-Ras4B.
Li X; Dai J; Ni D; He X; Zhang H; Zhang J; Fu Q; Liu Y; Lu S
Int J Biol Macromol; 2020 Feb; 144():643-655. PubMed ID: 31816384
[TBL] [Abstract][Full Text] [Related]
36. SOS1 interacts with Grb2 through regions that induce closed nSH3 conformations.
Liao TJ; Jang H; Fushman D; Nussinov R
J Chem Phys; 2020 Jul; 153(4):045106. PubMed ID: 32752665
[TBL] [Abstract][Full Text] [Related]
37. High-Affinity Interactions of the nSH3/cSH3 Domains of Grb2 with the C-Terminal Proline-Rich Domain of SOS1.
Liao TJ; Jang H; Nussinov R; Fushman D
J Am Chem Soc; 2020 Feb; 142(7):3401-3411. PubMed ID: 31970984
[TBL] [Abstract][Full Text] [Related]
38. The quaternary assembly of KRas4B with Raf-1 at the membrane.
Jang H; Zhang M; Nussinov R
Comput Struct Biotechnol J; 2020; 18():737-748. PubMed ID: 32257057
[TBL] [Abstract][Full Text] [Related]
39. Biophysical Characterization of RAS-SOS Complexes by Native Mass Spectrometry.
Yun S; Scott E; Laganowsky A
Methods Mol Biol; 2024; 2797():177-193. PubMed ID: 38570460
[TBL] [Abstract][Full Text] [Related]
40. Quantifying intramolecular binding in multivalent interactions: a structure-based synergistic study on Grb2-Sos1 complex.
Sethi A; Goldstein B; Gnanakaran S
PLoS Comput Biol; 2011 Oct; 7(10):e1002192. PubMed ID: 22022247
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
